Financials
- Market Capitalization 532.97 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry 診断・研究
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-7.25
売上高対価格比率
1.9
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2445 | CSTL Castle Biosciences, Inc. - Common stock | 33.03 USD | -1.40% | -1.31% | +18.68% | +34.19% | 1.01 B USD | ||
| 2521 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.05 USD | +0.67% | -5.62% | +16.57% | +211.86% | 890.55 M USD | ||
| 2996 | PRE Prenetics Global Limited - Class A Ordinary Share | 26.25 USD | +1.90% | +17.98% | +34.96% | +232.28% | 442.94 M USD | ||
| 3299 | MYGN Myriad Genetics, Inc. - Common Stock | 3.22 USD | +1.90% | +5.23% | +12.59% | -61.06% | 307.99 M USD |